Newron Pharmaceuticals SpA (NWRN) — Financial Flexibility Index
Newron Pharmaceuticals SpA (NWRN) has a Financial Flexibility Index of -0.03x as of December 2025. Free cash flow of CHF-1.31 Million (operating CF CHF-1.33 Million minus capex CHF15.73K) represents 0% of total liabilities (CHF51.15 Million). Check NWRN strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Newron Pharmaceuticals SpA Financial Flexibility Index (2005–2025)
Historical Financial Flexibility Index trend for Newron Pharmaceuticals SpA across 21 annual periods. See Newron Pharmaceuticals SpA working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Newron Pharmaceuticals SpA (2005–2025)
Year-by-year free cash flow to debt coverage for Newron Pharmaceuticals SpA. For the full company profile including market capitalisation, see market value of Newron Pharmaceuticals SpA.
| Year | Flexibility Index | Free Cash Flow (CHF) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.64x | CHF32.61 Million | CHF32.56 Million | CHF51.15 Million | ▲ +326.2% |
| 2024 | -0.28x | CHF-17.60 Million | CHF-17.61 Million | CHF62.45 Million | ▼ -55.2% |
| 2023 | -0.18x | CHF-10.13 Million | CHF-10.14 Million | CHF55.77 Million | ▲ +16.0% |
| 2022 | -0.22x | CHF-11.07 Million | CHF-11.09 Million | CHF51.23 Million | ▲ +10.3% |
| 2021 | -0.24x | CHF-11.43 Million | CHF-11.45 Million | CHF47.38 Million | ▲ +47.4% |
| 2020 | -0.46x | CHF-15.55 Million | CHF-15.59 Million | CHF33.95 Million | ▲ +50.9% |
| 2019 | -0.93x | CHF-21.93 Million | CHF-21.98 Million | CHF23.49 Million | ▲ +69.7% |
| 2018 | -3.08x | CHF-15.92 Million | CHF-15.95 Million | CHF5.16 Million | ▼ -95.1% |
| 2017 | -1.58x | CHF-8.38 Million | CHF-8.40 Million | CHF5.30 Million | ▲ +44.6% |
| 2016 | -2.85x | CHF-19.51 Million | CHF-19.58 Million | CHF6.84 Million | ▼ -61.9% |
| 2015 | -1.76x | CHF-12.80 Million | CHF-12.86 Million | CHF7.27 Million | ▼ -37.9% |
| 2014 | -1.28x | CHF-9.98 Million | CHF-10.00 Million | CHF7.81 Million | ▼ -26.8% |
| 2013 | -1.01x | CHF-10.61 Million | CHF-10.69 Million | CHF10.53 Million | ▼ -394.2% |
| 2012 | 0.34x | CHF5.84 Million | CHF5.83 Million | CHF17.04 Million | ▲ +148.4% |
| 2011 | -0.71x | CHF-4.94 Million | CHF-4.94 Million | CHF6.98 Million | ▲ +74.3% |
| 2010 | -2.75x | CHF-19.12 Million | CHF-19.13 Million | CHF6.94 Million | ▼ -48.5% |
| 2009 | -1.85x | CHF-22.99 Million | CHF-23.06 Million | CHF12.39 Million | ▼ -39.6% |
| 2008 | -1.33x | CHF-19.57 Million | CHF-19.93 Million | CHF14.73 Million | ▼ -27.4% |
| 2007 | -1.04x | CHF-13.53 Million | CHF-13.87 Million | CHF12.97 Million | ▼ -99.3% |
| 2006 | -0.52x | CHF-9.58 Million | CHF-9.63 Million | CHF18.30 Million | ▲ +76.2% |
| 2005 | -2.20x | CHF-14.23 Million | CHF-14.33 Million | CHF6.48 Million | — |